快而精醫藥 QGEN 深 滬
已收盤 06-05 16:00:00 美东时间
36.68
-0.880
-2.34%
華盛通- 最 高37.81
- 今 開37.67
- 成交量 141.29万股
- 最 低 36.54
- 昨 收 37.56
- 總市值 756.53万
- 52周最高 57.815
- 市盈率 靜 17.95
- 換手率 685.03%
- 52周最低 32.53
- 委 比 15.91%
- 總股本 0.00亿
- 歷史最高 60.3887
- 量 比 0.52
- 振 幅 3.38%
- 歷史最低 7.7822
- 每 手 1
- 風險率 4.98%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股夜盘 | 泰勒·莫里森家涨20.00%，Hyperliquid Strategies, Inc涨17.32%
泰勒·莫里森家涨20.00%；Hyperliquid Strategies, Inc涨17.32%；Summit Therapeutics Inc涨16.02%
06-01 10:01
美股大行评级 | 花旗上调英特尔目标价至130美元；大摩上调英伟达目标价至285美元；National 、Yesway获多家大行首予买入评级
今日重点评级关注：TD Cowen：维持Strive"买入"评级，目标价从28美元升至30美元；蒙特利尔银行：维持KinderCare Learning"跑赢大市"评级，目标价从4美元升至6美元
05-19 10:55
Stifel Maintains Hold on Qiagen, Lowers Price Target to $36
Stifel analyst Daniel Arias maintains Qiagen (NYSE:QGEN) with a Hold and lowers the price target from $50 to $36.
05-19 00:53
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
QIAGEN Plans To Advance QuantiFERON Latent TB Test With Automated Sample To Insight Workflow And Separate AI-Enabled Risk Stratification Tool For TB Progression
Ambition to support high-throughput laboratories in efficiently scaling latent tuberculosis (TB) screening as testing volumes continue to growFully automated workflow targeted for late 2027 launch integrates QuantiFERON
05-07 18:06
UPDATE: Qiagen FY2026 expected to be more than $2.43 vs $2.51 Est; Affirms FY2026 Sales Guidance of $2.111B-$2.132B vs $2.183B Est
Qiagen (NYSE:QGEN) FY2026 expected to be more than $2.43 vs $2.51 Est. affirms FY2026 sales outlook from $2.111 billion-$2.132 billion to $2.111 billion-$2.132 billion vs $2.183 billion estimate.
05-07 05:48
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
美股大行评级 | 瑞银：维持Visa"买入"评级！目标价从390美元升至410美元
今日重点评级关注：HC Wainwright & Co.：维持Protara Therapeutics"买入"评级，目标价从23美元升至27美元；BTIG：维持Black Diamond Therapeutic"买入"评级，目标价从10美元升至11美元
04-30 19:24
This Crane Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Analysts upgraded Qiagen, Armstrong World, T-Mobile, Crane Co, and Centene Corp stocks, with price target changes. See their ratings and views.
04-29 19:35
Baird Upgrades Qiagen to Outperform, Lowers Price Target to $43
Baird analyst Catherine Schulte upgrades Qiagen (NYSE:QGEN) from Neutral to Outperform and lowers the price target from $53 to $43.
04-29 17:19
